Close Menu

NEW YORK — The US Food and Drug Administration has reissued an Emergency Use Authorization for Helix's PCR-based SARS-CoV-2 test, allowing its use with self-collected specimens and in asymptomatic individuals for screening or population-based testing, the company said on Monday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.